What is the current Amedisys market capitalization?
The current market capitalization of Amedisys is 2.99 B USD.
Amedisys Market capitalization 2024
Amedisys Market capitalization
2.99 B USD
Ticker
AMED
ISIN
US0234361089
WKN
915582
In 2024, Amedisys's market cap stood at 2.99 B USD, a 0.96% increase from the 2.96 B USD market cap in the previous year.
The Amedisys Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2026e | 2.68 | 36,99 | 151 |
| 2025e | 2.51 | 39,43 | 166.13 |
| 2024e | 2.38 | 41,69 | 153.25 |
| 2023 | 2.24 | 44,31 | -9.75 |
| 2022 | 2.22 | 43,71 | 118.6 |
| 2021 | 2.21 | 45,83 | 209.1 |
| 2020 | 2.07 | 42,78 | 183.6 |
| 2019 | 1.96 | 41,18 | 126.8 |
| 2018 | 1.66 | 40,28 | 119.3 |
| 2017 | 1.51 | 40,22 | 30.3 |
| 2016 | 1.42 | 41,21 | 37.3 |
| 2015 | 1.28 | 43,31 | -3 |
| 2014 | 1.2 | 42,63 | 12.8 |
| 2013 | 1.25 | 42,53 | -96.2 |
| 2012 | 1.44 | 43,73 | -83.6 |
| 2011 | 1.42 | 47,09 | -382.5 |
| 2010 | 1.6 | 50,41 | 112.6 |
| 2009 | 1.48 | 52,47 | 135.8 |
| 2008 | 1.19 | 52,62 | 86.7 |
| 2007 | 0.7 | 52,86 | 65.1 |
| 2006 | 0.54 | 53,39 | 38.3 |
| 2005 | 0.38 | 57,26 | 30.1 |
| 2004 | 0.23 | 57,68 | 20.5 |
Amedisys Aktienanalyse
What does Amedisys do?
Amedisys Inc is a US home healthcare provider that offers a variety of healthcare services in the private home, including home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. The company was founded in 1982 by William F. Borne and Michael J. Borne and is headquartered in Baton Rouge, Louisiana. History In the 1980s, while William and Michael Borne were running a nursing home together, they recognized a demand for home healthcare and founded Amedisys in 1982. The company started with a small group of nurses making house calls and was based on the belief that people would prefer to be cared for at home rather than being placed in a facility. In 1999, Amedisys was acquired by the American Stock Exchange and was able to steadily improve its performance and expand its business model to multiple states. In 2007, the company went public and has been listed on NASDAQ since. Business Model Amedisys offers a wide range of healthcare services that are typically received by patients at home. The services include home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. Amedisys collaborates with over 360 medical faculties and over 7,500 medical professionals who provide healthcare to over 385,000 patients per year. Amedisys also offers training programs for nurses and other employees to discover the business and potential growth opportunities. The company relies on teamwork to motivate staff and keep their knowledge and skills up-to-date. Segments Amedisys operates in two main business segments: home healthcare and hospice care. Both segments offer specialized services and are provided by professionals such as registered nurses, therapists, medical assistants, and social workers. The company has more than 435 hospice facilities in 34 US states and over 197 home healthcare branches in 38 US states. Products Amedisys offers a variety of products, including infusion therapy, professional wound management, clinical respiratory therapy, polypharmacy management, specialized care services, and palliative care. The company also provides telemedicine options for patients to receive care from home. Summary Amedisys is a leading provider of home healthcare and hospice care in the US. The company offers a wide range of services and is able to serve both the inpatient and outpatient settings. The company relies on teamwork to provide comprehensive and high-quality care to patients. Amedisys is a successful and expanding company that is also exploring new market potentials through the use of technology. Amedisys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Amedisys's Market Capitalization
Amedisys's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Amedisys's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Amedisys's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Amedisys’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Amedisys Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Amedisys.
How has the market capitalization of Amedisys developed in recent years?
The market capitalization of Amedisys has increased/decreased by 0.96% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Amedisys?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Amedisys?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Amedisys have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Amedisys pay?
Over the past 12 months, Amedisys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amedisys is expected to pay a dividend of 0 USD.
What is the dividend yield of Amedisys?
The current dividend yield of Amedisys is .
When does Amedisys pay dividends?
Amedisys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Amedisys?
Amedisys paid dividends every year for the past 0 years.
What is the dividend of Amedisys?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Amedisys located?
Amedisys is assigned to the 'Health' sector.
Wann musste ich die Aktien von Amedisys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Amedisys from 6/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/25/2024.
When did Amedisys pay the last dividend?
The last dividend was paid out on 6/25/2024.
What was the dividend of Amedisys in the year 2023?
In the year 2023, Amedisys distributed 0 USD as dividends.
In which currency does Amedisys pay out the dividend?
The dividends of Amedisys are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Amedisys stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Amedisys
Our stock analysis for Amedisys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
